Brilliant Violet 510TM anti-human CD57 Recombinant [QA17A04] and 2 more items
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0452690
- Awardee
- BIOLEGEND INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $867.55
About this award
The University of Virginia awarded a contract to BioLegend Inc. on June 25, 2026, for the procurement of specialized laboratory reagents in support of immunological research activities. The contract, identified as A207_PO-0452690, is valued at eight hundred sixty-seven dollars and encompasses three distinct flow cytometry antibody products. All deliverables are consigned to Abhinav Arneja at the University of Virginia in Virginia.
The procurement includes three monoclonal antibody reagents: Brilliant Violet 510 anti-human CD57 Recombinant (catalog QA17A04) at $318.00, Fluorescein Isothiocyanate (FITC) anti-human T Cell Receptor Cbeta1 (catalog JOVI.1) at $223.30, and Brilliant Violet 711 anti-human CD45RA (catalog HI100) at $326.25. Each line item represents a single unit purchase. These reagents are standard immunofluorescence research supplies used for cell identification and characterization in flow cytometry applications.
Line items
| Item | Total |
|---|---|
| Brilliant Violet 510TM anti-human CD57 Recombinant [QA17A04] | $318.00 |
| FITC anti-human TCR Cbeta1 [JOVI.1] | $223.30 |
| Brilliant Violet 711TM anti-human CD45RA [HI100] | $326.25 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0452690?
Contract A207_PO-0452690 was awarded to BIOLEGEND INC. by University of Virginia on June 25, 2026.
How much is contract A207_PO-0452690 worth?
Its cumulative value is $867.55.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award